Robert is a highly strategic and results focussed private health care leader. With a 40+ year career in the health industry, his experience spans executive leadership of publicly listed and privately owned healthcare companies, and management of private and public hospitals in Australia, Asia and the UK.

He has a proven track record in setting strategy and delivering successful outcomes for stakeholders and shareholders, highly effective interaction with the financial community, and holds a unique understanding of the complex dynamics of the health care industry. Robert is the former Managing Director & CEO of Healthscope, one of Australia’s leading private hospital, medical centre and pathology operators between 2010 and 2017.

He is currently a non-executive director of Icon Group and Evercare Group. Icon Group is an operator of cancer centres, specialist services, pharmacy management, compounding, remote care, research and health screening services in Australia, Singapore, Hong Kong and Mainland China, Vietnam and New Zealand. The Evercare Group is a leading impact driven healthcare group in emerging markets. The Group operates across South East Asia and Africa with 30 hospitals, 16 clinics and 82 diagnostic centres.

MBA, MAICD, PhD, FRACDS(OralMed), FAIM

Dr Camile Farah is a highly accomplished executive, clinician, researcher and academic with 25 years’ experience in the healthcare, biotech and medical research sectors. He has a proven track record in organisational leadership and excellence in the healthcare industry with expertise in building successful businesses.

Dr Camile is a dual trained oral medicine specialist and oral & maxillofacial pathologist, with multiple public and private appointments. He is a leading international figure in oral cancer and precancerous pathology based on his clinical and research expertise having published 250 clinical and scientific articles and a bestselling textbook. He is independently ranked #1 Australian and top 10 international expert in these domains by expertscape.com.

Dr Camile has held numerous leadership roles in healthcare and medical research, most recently as Dean and Chief Executive at the University of Western Australia. Currently, he holds an Adjunct Professorship at CQ University and an Honorary Professorial Research Fellowship at the Peter MacCallum Cancer Centre. In addition to managing his own consulting business, Camile is Executive Director of the Australian Centre for Oral Oncology Research & Education which undertakes cutting edge research in head and neck oncology.

Dr Camile has a global network of international collaborations, and has been involved in research and development and clinical implementation and testing of many optical imaging technologies including optical fluorescence imaging, narrow band imaging, optical coherence tomography and confocal laser endomicroscopy.

Ron had a 25 year business career in Australia before being headhunted in 1999 to assist in expanding a European motor vehicle franchise in Singapore.

In a short time, Ron assisted in developing the franchise into a highly profitable business. He subsequently expanded and developed a second company in the motor vehicle industry, Premium Automobiles Pte Ltd, where he was the Managing Director for seven years before advising and developing a premier Singaporean wellness company, Fabulous Image Lifestyle, which was successfully sold to a pan-Asian operator.

Ron has established a network of business contacts in many areas of enterprise in Asia and Australia. He has contacts in the health sector in Asia as well as associations with businesses and the financial sector in Australia and Asia which will be valuable to Optiscan. He is an existing shareholder of the Company.

Karen is a highly regarded senior private and public sector leader, with significant experience in medical devices and technology, consumer products and government services. Karen has held senior roles in international and national commercial management, global marketing and government.

Karen is the former President (Asia Pacific and Middle East) of ResMed Inc (ASX: RMD) and prior to this held several senior roles with Johnson & Johnson Medical Devices, including Global Vice President (based in USA). Karen’s most recent executive roles include CEO of Healthdirect and inaugural Chief Executive of Jobs for NSW, with both roles fostering relationships across all tiers of government. Karen also holds several non- executive roles and is on the Board of Somnomed Ltd (ASX: SOM), The North Foundation and is the Interim Chair of the Australian Vaccine Research Alliance.

Karen holds Bachelor of Arts from the University of Sydney and was a NSW finalist for Telstra Business Woman of the Year 2017.

Sean is a Managing Director and Head of Private Investments at the Clermont Group. Prior to joining Clermont, Sean worked at Morgan Stanley, where he spent 20 years in equity research across three locations and in seven different roles.

In 2000, he joined the London office, covering European Technology and Conglomerate stocks before, in 2005, moving to lead the EEMEA Telecom Services team. In early 2008, Sean transferred to Dubai to setup and manage the MENA Equity Research team. Sean relocated to Singapore in 2010 to oversee and manage the broader Asian research product as well as roll out ASEAN Real Estate coverage. In 2016, he was promoted to Head of ASEAN Research and ASEAN Equity Strategist. Prior to Morgan Stanley, Sean served his Chartered Accountancy articles in South Africa and he has a B.Com (PGDA) from the University of Cape Town.